Ang2 was significantly higher in ICU patients with COVID-19 requiring IMV compared to those who did not (Table 4, Fig. 4D), as was thrombomodulin (Table 4,Fig. 4E) and vWF:Ag (Table 4, Fig. 4F). This evidence concerns the gene ANGPT2 and COVID-19.